Discover

HIMS
Hims & Hers Health, Inc.
37.57
200 x undefined
500 x undefined
bid
ask
+
2.90
8.36%
350 @ 06:25 AM
37.39 -0.18 (0.48%)
Ytd15.71%
1y-21.66%
34.75
day range
38.50
13.74
52 week range
70.43
Open35.10Prev Close34.67Low34.75High38.50Mkt Cap8.70B
Vol25.20MAvg Vol25.18MEPS-0.09P/EN/AForward P/E42.17
Beta2.40Short Ratio3.41Inst. Own69.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1050-d Avg28.22200-d Avg32.751yr Est28.35

HIMS News

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years
benzinga.com
Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an

Hims & Hers Stock Surges as Analysts Lift Price Targets
benzinga.com
Hims & Hers Stock Surges as Analysts Lift Price Targets

Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Ca

Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review
invezz.com
Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review

Hims & Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its price tar

Hims & Hers Health’s Peptide Opportunity Tempered By FDA Recommendation, Says Analyst
benzinga.com
Hims & Hers Health’s Peptide Opportunity Tempered By FDA Recommendation, Says Analyst

HIMS facing negative impact on peptide optionality due to FDA's recommendation against adding 7

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
zacks.com
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes

benzinga.com
Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $40

Canaccord Genuity analyst Maria Ripps maintains Hims & Hers Health (NYSE:HIMS) with a Buy and

benzinga.com
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $36

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral

Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know
zacks.com
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know

In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $33.39, indicating a -

10 Health Care Stocks With Whale Alerts In Today’s Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

OMCL or HIMS: Which Is the Better Value Stock Right Now?
zacks.com
OMCL or HIMS: Which Is the Better Value Stock Right Now?

Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Him

benzinga.com
Eli Lilly Announces Additional Details On Medicare GLP-1 Bridge Program From July 1; Medicare Part D

The Medicare GLP-1 Bridge program will be the first time eligible Medicare Part D patients will be a

Hims' obesity drug business may get boost as employers drop coverage
reuters.com
Hims' obesity drug business may get boost as employers drop coverage

Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage

Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today
benzinga.com
Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an

benzinga.com
CVS Pharmacy Announces New GLP-1 Offerings, Including Expanded Pharmacy Support And A New $49 Minute

As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today

Hims & Hers Stock Jumps After Barclays Raises Price Target
benzinga.com
Hims & Hers Stock Jumps After Barclays Raises Price Target

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance

benzinga.com
Barclays Maintains Overweight on Hims & Hers Health, Raises Price Target to $39

Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight a

Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know
benzinga.com
Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher on Tuesday as the stock continues t

Hims & Hers Stock Is Surging Monday: What's Driving The Move?
benzinga.com
Hims & Hers Stock Is Surging Monday: What's Driving The Move?

Hims & Hers shares are jumping Monday afternoon, staging a sharp rebound after a wave of profit-

Hims & Hers Health Stock Slides Friday: What's Going On?
benzinga.com
Hims & Hers Health Stock Slides Friday: What's Going On?

Hims & Hers Health is trading lower Friday as stock digests CMO appointment and gives back repai

Hims & Hers Stock Edges Higher: What's Going On?
benzinga.com
Hims & Hers Stock Edges Higher: What's Going On?

Hims & Hers Health shares are trading higher on Tuesday as investors react to a new chief medica

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

Hims & Hers Stock Jumps: What's Happening Today?
benzinga.com
Hims & Hers Stock Jumps: What's Happening Today?

Shares of Hims & Hers Health are trading higher on Thursday as investors react to a new chief me

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session